D
D3 Bio
Building a global biotechnology company that develops innovative and more efficacious medicines for patients in need worldwide
News
Open roles
D3 Bio in the Wuxi ecosystem
The D3 Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- MEMedicxi
Matrix Partners China- HSHSG
- BCBoyu Capital
WuXi AppTec
Temasek
Series B and later2 investors entered at this stage
IDG Capital- MPMPCi
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Patents
14 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See D3 Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

